Moderator & Speaker Lineup

Labeeb M. Abboud, International AIDS Vaccine Initiative
Case Studies for Global Health: Building Relationships, Sharing Knowledge

Irene Abrams, Brandeis University
New Strategies for Funding University Innovation

Haskell Adler, University of Georgia Research Foundation, Inc.
Biogenerics and Biosimilars: Coming to America

Mary Albertson, Stanford University
Women in Technology Transfer: A Discussion on Rewriting the Rules

Vincie C. Albritton, M.B.A., Clemson University
The One Big Idea: Identifying the Most Critical Aspect in Running Your Small Office Technology Transfer Office

Michael F. Allan, Case Western Reserve University
Building a Stronger Community Through an International Resident Affiliate Program in Technology Transfer

Bryan T. Allinson, M.B.A.,
Understanding Incentives in the Diagnostic Marketplace

Bruce Artim, Eli Lilly & Co.
Biogenerics and Biosimilars: Coming to America

Gwilym Attwell, Fish & Richardson PC
Biogenerics and Biosimilars: Coming to America

Mary Augé , Partners Healthcare
From Cold Calls to Hot Deal

James R. Baker, Michigan Technological University
Experiences with Collaborative Technology Transfer Programs

Usha R. Balakrishnan, M.B.A., CARTHA
Technology Managers for Global Health

Edward Barrientos, Entrepreneur and Angel Investor
Elements for a Successful Startup

Jennifer Barron, M.B.A., Johns Hopkins Bloomberg School of Public Health
Intellectual Property Terms in University-Industry Research Agreements and MTAs

Seema Shah Basu, Ph.D., Massachusetts General Hospital
Tuning-in to Your Expert Network

Romain Beaume , Economy, Industry and Employment Ministry of France
Open Innovation and Public Research: Comparing American and European Practices

Matthew Bell, University of Michigan
Top Ten License Negotiation Pitfalls and How to Avoid Them

Louis P. Berneman, Ed.D., Texelerate LLC
Royalty Monetization: Deal Structures and Outcomes
Launching Startups in a Down Market

Peter I. Bernstein, J.D., Scully Scott Murphy & Presser
Patent Reform Act: New Developments

Allyson M. Best, M.B.A., University of Mississippi
Botanical Drugs: Navigating an Emerging BioPharma Pipeline

Lisa C. Beveridge , Baylor College of Medicine
Designing Effective Strategies for Marketing Newly Patented Technologies to Potential Licensees

Cherry Joy Beysselance, J.D., Howard Hughes Medical Institute
Material Transfer Agreements: Much Ado About Nothing?

Gina M. Bicknell, Marshall Gerstein & Borun LLP
Strategies to Get Licensees to Pay

Alpheus Bingham, Ph.D., InnoCentive, Inc.
Open Innovation: Where Has All My Intellectual Property Gone?

Wesley D. Blakeslee, Johns Hopkins University
AUTM Debate Forum: Perspectives on Patenting Genomic Inventions

Goldie Blumenstyk, Chronicle of Higher Education
Don't Be Afraid: Media Training for the Technology Transfer Professional

Dana Bostrom, Portland State University
Metrics and Public Policy
Creating a Software Commons

Victor H. Boyajian, Sonnenschein Venture Technology Group
Elements for a Successful Startup

Alex Brill, American Enterprise Institute for Public Policy Research
Biogenerics and Biosimilars: Coming to America

Judy Bristow, University of Louisville
Don't Be Afraid: Media Training for the Technology Transfer Professional

Elaine L. Brock, University of Michigan
Can You Build a Strong Community on Conflict of Interest Quicksand?

Daniel F. Broderick, California Institute of Technology
The Brave New World of Bilski

Charley F. Brown, J.D., Ballard Spahr LLP
Patent Reform Act: New Developments

Matthew Burnstein, Esq., Waller Lansden Dortch & Davis LLP
The Deal Points in a Preferred Stock Investment: Who Wants What and Why

Susan B. Butts, Ph.D., Dow Chemical Co.
Intellectual Property Terms in University-Industry Research Agreements and MTAs

Richard S. Cahoon, Ph.D., Cornell University
Licensing Ag-Bio Technologies

Yi Ping Chan, Chanden Inc.
Technology Licensing in China

Albert Wai-Kit Chan, Ph.D., J.D., Law Offices of Albert Wai-Kit Chan PLLC
Technology Licensing in China

Nona Cheeks, National Aeronautics and Space Administration
Open Innovation: Where Has All My Intellectual Property Gone?

Thomas Cherry, Cook Medical, Inc.
Physicians and Industry: Advancing Medicine Together

John M. Christie, Tulane University
Collaborative Agreements and Material Transfer Agreements in a Global Market

Jack W. Chung, Law Offices of Albert Wai-Kit Chan PLLC
Technology Licensing in China

Brian Clark, Ph.D., City of Hope National Medical Center
Material Transfer Agreements: Much Ado About Nothing?

Bruce D. Clary, University of Florida
Technology Transfer from A-Z

John D. Clements, Ph.D., Tulane University School of Medicine
Access to Medicines: Fostering Partnerships, Overcoming Challenges

Andrew Cohn, Wisconsin Alumni Research Foundation
Foundations that Provide Technology Transfer to Universities

Tamara L. Connelly-Calderon, M.B.A., Merck & Co., Inc.
Intellectual Property Terms in University-Industry Research Agreements and MTAs

Joseph M. Conrad III, Ph.D., J.D. , National Institutes of Health
NIH Funding Essentials, Maintaining Inventions and Other Intellectual Property Issues

David Conrad, Ph.D., M.B.A., NUtech Ventures
Strategies to Get Licensees to Pay

Robert M. Cook-Deegan, M.D., Duke University
AUTM Debate Forum: Perspectives on Patenting Genomic Inventions

Patricia Anderson Cotton, University of California
Technology Transfer Practitioners and Scholars: What Can We Learn from Each Other?

Pamela L. Cox, J.D., Marshall Gerstein & Borun LLP
Drafting the License Agreement: Let the Financial Terms Be Your Guide

Robert Creeden, Partners Innovation Fund
The Deal Points in a Preferred Stock Investment: Who Wants What and Why

Kevin E. Cullen, Ph.D., University of Glasgow
Metrics Successful Practices

Michael Curtotti, Australian National University
The Human Rights of Licensing

Nipon Das, M.D., Leerink Swann
Biogenerics and Biosimilars: Coming to America

Stewart N. Davis, ATCC
Potpourri of Agreements- An Overview of Six Common Technology Transfer Agreements

Benjamin C. de Boisblanc, M.D., Louisiana State University Health Sciences Center, School of Medicine
Physicians and Industry: Advancing Medicine Together

Monica de la Paz , Fulbright & Jaworski LLP
Ethics and Equitable Conduct: Procuring Enforceable Patents

Mandy W. Decker, Stites & Harbison PLLC
Biotechnology and Life Sciences Patent Protection

Charles Dennis, Medtronic, Inc.
The Brave New World of Bilski

Karen Denton, Bayer HealthCare Pharmaceuticals
Alliance Management: Maximizing Industrial, Academic and Biotech Interactions

Anne C. Di Sante, M.B.A., Wayne State University
Export Controls, MTAs and CDAs: What You Need to Know to Stay out of Trouble
Collaborative Agreements and Material Transfer Agreements in a Global Market
Can You Build a Strong Community on Conflict of Interest Quicksand?

Benjamin C. Dibling, Ph.D., University of Chicago
Ethics and Equitable Conduct: Procuring Enforceable Patents

Jeanne DiGiorgio, Lahive & Cockfield LLP
Patent Prosecution Strategy: Issues, Considerations and Solutions

Jinhui Dou, Ph.D. , U.S. Food and Drug Administration
Botanical Drugs: Navigating an Emerging BioPharma Pipeline

Rowan Douglas, Willis Research Network
Sharing Data and Assets Across Industry and Academia to Drive the Science Base and Innovation

Kathryn R. Doyle, Ph.D., J.D., Drinker Biddle & Reath LLP
Global Patent Protection – Why You Need It and How to Get It

Claire T. Driscoll, National Institutes of Health
NIH Funding Essentials, Maintaining Inventions and Other Intellectual Property Issues

Monya Dunlap, University of Florida
Technology Transfer from A-Z

Joshua Eades , University of British Columbia
Case Studies for Global Health: Building Relationships, Sharing Knowledge

Mark Edwards, Deloitte Recap LLC
Successful Practices in University-Biotech Technology Transfer

Ronald I. Eisenstein, J.D., Nixon Peabody LLP
Dealing with the Attack On The Patentability of Personalized Medicine and Diagnostic Patents

Gerard Eldering, M.B.A., InnovateTech Ventures
Elements for a Successful Startup

James Scott Elmer, J.D., St. Jude Children's Research Hospital
Potpourri of Agreements- An Overview of Six Common Technology Transfer Agreements

Janis Elsner , Vanderbilt University
Using In-reach As a Powerful Tool for Nurturing Relationships Inside Your University

Henry Etzkowitz, Clayman Institute for Gender Research, Stanford University and Edinburgh University Business School
Women in Technology Transfer: A Discussion on Rewriting the Rules

Frederic Farina, California Institute of Technology
Open Innovation and Public Research: Comparing American and European Practices

Kevin M. Farrell, J.D., Pierce Atwood
In re Bilski: Implications for Business Methods and Biotechnological Processes

Christopher M. Fender, University of Missouri
The Art of Protecting Life Science Inventions

Steven M. Ferguson, CLP, National Institutes of Health
NIH Funding Essentials, Maintaining Inventions and Other Intellectual Property Issues

Carla H. Fishman, Louisiana State University System
Women in Technology Transfer: A Discussion on Rewriting the Rules

Stephen Fleming, Georgia Institute of Technology
Startups: Learning from Real Life Experiences

Joseph D. Fondacaro, Ph.D., Fondacaro & Associates Consulting
From Cold Calls to Hot Deal

Steve Foster, NeoTREX, Colorado State University
Drafting the License Agreement: Let the Financial Terms Be Your Guide

John A. Fraser, Florida State University
Creating and Funding Globally Competitive University Startups

Michael R. Friscia, J.D., McCarter & English LLP
In re Bilski: Implications for Business Methods and Biotechnological Processes

David Gani, University of Strathclyde
Metrics and Public Policy

Michael Gara, Wallace H. Coulter Foundation
New Strategies for Funding University Innovation

Soumitra Ghosh, Ph.D., Bayer Business & Technology Services
Successful Practices in University-Biotech Technology Transfer

Eric W. Giegerich , University of California, Berkeley
Creating a Software Commons

Bruce Gingles, COOK Medical, Inc.
Physicians and Industry: Advancing Medicine Together

Michael L. Goldman, J.D., Nixon Peabody LLP
Licensing Ag-Bio Technologies

Bruce Goldstein, J.D., National Institutes of Health
AUTM Debate Forum: Perspectives on Patenting Genomic Inventions

Andrew K. Gonsalves, Esq., Heslin Rothenberg Farley & Mesiti PC
Botanical Drugs: Navigating an Emerging BioPharma Pipeline

Philippe Gorry, M.D., Ph.D., Université Bordeaux 2
Open Innovation and Public Research: Comparing American and European Practices

Jaideep Goswami, North Dakota State University
Designing Effective Strategies for Marketing Newly Patented Technologies to Potential Licensees

Gregory Graff, Colorado State University
The Legal Context of University Intellectual Property and Technology Transfer

David G. Grossman, George Mason University
Non-Traditional Departments As a Resource in Technology Transfer

Robert R. Gruetzmacher, Ph.D., CLP, Rutgers, The State University of New Jersey
Open Innovation: Where Has All My Intellectual Property Gone?

Maneesh Gulati, Lahive & Cockfield LLP
Patent Prosecution Strategy: Issues, Considerations and Solutions

Carl Gulbrandsen, Ph.D., J.D., Wisconsin Alumni Research Foundation
Stem Cells: Presidents and Precidents

David L. Gulley, Ph.D., University of Illinois
Cash or Credit: Incorporating Students Into Daily Technology Licensing Office Operations

Matthew Hamilton, Ph.D., Wellspring Worldwide
It's Not Easy Being Green: The Challenges of Startups and Innovation in Cleantech

Organized by - Ann M. Hammersla, J.D., National Institutes of Health
AUTM Debate Forum: Perspectives on Patenting Genomic Inventions

Randy Hansen, Innovation Emporium, Inc.
Experiences with Collaborative Technology Transfer Programs

Robert E. Hanson, Ph.D., J.D., Sonnenschein Nath & Rosenthal LLP
The Art of Protecting Life Science Inventions

Diane Harbison, Ph.D. , Pfizer, Inc.
Stem Cells: Presidents and Precidents

Robert B. Hardy, J.D., Council on Governmental Relations
Patent Reform Act: New Developments

Brad Hargreaves , LabApp
Creating a Software Commons

Stephen G. Harsy, Ph.D., University of Wisconsin-Madison
Potpourri of Agreements- An Overview of Six Common Technology Transfer Agreements
Intellectual Property Terms in University-Industry Research Agreements and MTAs

Shawn A. Hawkins, St. Jude Children's Research Hospital
Metrics Successful Practices

Wayne D. Hawthorne, Nationwide Children's Hospital
Intellectual Property 101: Patents, Trademarks and Copyrights

Todd Headley, Colorado State University
Drafting the License Agreement: Let the Financial Terms Be Your Guide

Lee C. Heiman, J.D.,
Technology Transfer from A-Z

R. Page Heller, Hopes Creek Consulting
Designing Effective Strategies for Marketing Newly Patented Technologies to Potential Licensees

Michael W. Henry , Athena Diagnostics, Inc.
AUTM Debate Forum: Perspectives on Patenting Genomic Inventions

Mikael Herlevsen, Ph.D., University of Virginia Patent Foundation
Non-Traditional Departments As a Resource in Technology Transfer

Karen Hersey, J.D., Franklin Pierce Law Center
Women in Technology Transfer: A Discussion on Rewriting the Rules

Orin Herskowitz, Columbia Technology Ventures
Access to Medicines: Fostering Partnerships, Overcoming Challenges

Brian N. Hicks, M.B.A., Partners Healthcare System
Successful Processes to Evaluate Inventions and Manage Stakeholder Expectations

Joseph O. Hill, Ph.D., Medical College of Wisconsin
Technology Transfer Practitioners and Scholars: What Can We Learn from Each Other?

Doug Hockstad , University of Michigan
Software and Copyright Marketing and Licensing
Creating a Software Commons

Richard C. Holdren, Healthcare Angels
How to Get Angel Money

Krisztina Holly, University of Southern California
New Strategies for Funding University Innovation

David E. Huizenga, Ph.D., J.D., Arnall Golden Gregory LLP
Patent Reform Act: New Developments
In re Bilski: Implications for Business Methods and Biotechnological Processes

Johan Hyllner, Ph.D., Cellartis AB
Stem Cells: Presidents and Precidents

Catherine Innes, University of North Carolina at Chapel Hill
Startups: Learning from Real Life Experiences

Erik Iverson, Bill & Melinda Gates Foundation
Case Studies for Global Health: Building Relationships, Sharing Knowledge

Jitendra Jain, The University of Texas at Austin
From Cold Calls to Hot Deal
Comparative Licensology: How License Terms Vary by Technology

J. Michael Jakes, Esq., Finnegan Henderson Farabow Garrett & Dunner LLP
The Brave New World of Bilski

Jonathan Jensen, Boston University
Tuning-in to Your Expert Network

Keith Jones Ph.D., Washington State University Research Foundation
Licensing Ag-Bio Technologies

Patrick L. Jones, Ph.D., University of Arizona
Startups: Learning from Real Life Experiences

Karen Kaehler, M.B.A., University of Minnesota
Successful Processes to Evaluate Inventions and Manage Stakeholder Expectations

Seong K. Kang, Ph.D., ORIGIN Patent & Law Firm
Software Patenting: Process and Strategy from the U.S. and International Perspectives

Kef Kasdin, Battelle Ventures
Elements for a Successful Startup

Chase Kasper, Mississippi State University
The Pros and Cons of a $1000 Provisional Patent Application

Renee Kaswan, IPAdvocate.org
AUTM Debate Forum: Role of Inventors in Negotiating License Transactions

Janet L. Kelly, Wisconsin Alumni Research Foundation
Don't Be Afraid: Media Training for the Technology Transfer Professional

Esther Kepplinger , Wilson Sonsini Goodrich & Rosati
You Can't Patent That! Can You?

Marie Kerbeshian, Ph.D., Indiana University Research and Technology Corporation
The Art Form We Call Negotiation

J.P. Kim, National Institutes of Health
NIH Funding Essentials, Maintaining Inventions and Other Intellectual Property Issues
Can You Build a Strong Community on Conflict of Interest Quicksand?

Alex Kinnier, Ph.D., Khosla Ventures
It's Not Easy Being Green: The Challenges of Startups and Innovation in Cleantech

Charles M. Kinzig, GlaxoSmithKline
Access to Medicines: Fostering Partnerships, Overcoming Challenges

Joerg Knaeblein, Bayer Schering Pharma AG
Fostering Better Relations while Accelerating Transfer of Innovations to Big Pharma

Richard Kordal, Ph.D., Louisiana Tech University
Comparative Licensology: How License Terms Vary by Technology

Brian Laden, Ph.D., TriStar Technology Ventures
Academic-Industry Partnerships in Drug Discovery

Vincent Lamande, Réseau C.U.R.I.E.
Open Innovation and Public Research: Comparing American and European Practices

Julia Lane, National Science Foundation
Metrics and Public Policy

Joan Lasota, Ph.D., Merck & Co., Inc.
Alliance Management: Maximizing Industrial, Academic and Biotech Interactions

Kay A. Lawton, Ph.D., Metabolon, Inc.
Understanding Incentives in the Diagnostic Marketplace

David Ledbetter, Emory University
Understanding Incentives in the Diagnostic Marketplace

James Lenhard, Johnson & Johnson
Academic-Industry Partnerships in Drug Discovery

Debra G.B. Leonard, M.D., Ph.D., Weill Cornell Medical College and New York-Presbyterian Hospital
AUTM Debate Forum: Perspectives on Patenting Genomic Inventions

Monika Lessl, Ph.D., Bayer Schering Pharma AG
Alliance Management: Maximizing Industrial, Academic and Biotech Interactions

Brian J. Libby, Ph.D., J.D. , Partners HealthCare
Dealing with the Attack On The Patentability of Personalized Medicine and Diagnostic Patents

Paul C.B. Liu, Ph.D., National Chengchi Unversity, Cornerstone Intellectual Property Foundation
International Members

Wen-Yu Lo, Amica Law LLC
Software Patenting: Process and Strategy from the U.S. and International Perspectives

Beverly A. Lyman, Ph.D., Esq. , Thompson Hine LLP
Biogenerics and Biosimilars: Coming to America

Robert S. MacWright, Ph.D., J.D., Frommer Lawrence & Haug LLP
AUTM Debate Forum: Role of Inventors in Negotiating License Transactions
The Art Form We Call Negotiation

Marc S. Malandro, Ph.D., University of Pittsburgh
Tuning-in to Your Expert Network

Thomas Marron, Eli Lilly & Co.
Alliance Management: Maximizing Industrial, Academic and Biotech Interactions

Kate Marusina, Ph.D., M.B.A., University of California Davis
Material Transfer Agreements: Much Ado About Nothing?

Thomas F. Meagher, J.D., Volpe & Koenig PC
Intellectual Property Enforcement Issues for Universities

Meryle Melnicoff , The Wistar Institute
Royalty Monetization: Deal Structures and Outcomes

Rebecca A. Menapace, M.B.A., Massachusetts General Hospital
How to Get Your Inventors Psyched, But Not Too Psyched!

Mary An Merchant, Ph.D., J.D., Ballard Spahr LLP
Intellectual Property Enforcement Issues for Universities

Stephen A. Merrill, Ph.D., National Academies of Sciences
Metrics and Public Policy

Jennifer Miller, University of North Carolina, Chapel Hill
Technology Transfer Practitioners and Scholars: What Can We Learn from Each Other?

Joseph B. Milstein, Ph.D., P.E., Esq. , Milstein Zhang & Wu LLC
The Brave New World of Bilski

Carol Mimura, Ph.D., University of California, Berkeley
Access to Medicines: Fostering Partnerships, Overcoming Challenges
The Human Rights of Licensing

Sherley Mizzell, National Institutes of Health
NIH Funding Essentials, Maintaining Inventions and Other Intellectual Property Issues

Marcel D. Mongeon, M.B.A., LL.B., Mongeon Consulting, Inc.
AUTM Debate Forum: Role of Inventors in Negotiating License Transactions

Joyce Morrison, Boehringer Ingelheim Vetmedica, Inc.
Collaborative Agreements and Material Transfer Agreements in a Global Market

Christopher T. Moulding, M.B.A., USC Stevens Institute for Innovation
Successful Practices in University-Biotech Technology Transfer

Matthew Mroz, The Research Foundation of SUNY
Patent Reform Act: New Developments

Jane Muir, University of Florida
From Cold Calls to Hot Deal

Polly A. Murphy, D.V.M., Ph.D., Pfizer, Inc.
Fostering Better Relations while Accelerating Transfer of Innovations to Big Pharma

Jennifer O. Murphy, M.B.A., George Mason University
Startups: Learning from Real Life Experiences

Jeffrey Myers, Southern Illinois University
Potpourri of Agreements- An Overview of Six Common Technology Transfer Agreements

Dipanjan Nag, Ph.D., M.B.A., Rutgers, The State University of New Jersey
Open Innovation: Where Has All My Intellectual Property Gone?

Allan Naidoff, D.M.D., J.D., Merck & Co., Inc.
Alliance Management: Maximizing Industrial, Academic and Biotech Interactions
Fostering Better Relations while Accelerating Transfer of Innovations to Big Pharma

Hassan Naqvi, Ph.D., Cleveland Clinic Innovations
How to Get Your Inventors Psyched, But Not Too Psyched!

William H. Needle, J.D., Ballard Spahr LLP
Intellectual Property 101: Patents, Trademarks and Copyrights

Lita Nelsen, M.B.A., Massachusetts Institute of Technology
Women in Technology Transfer: A Discussion on Rewriting the Rules

Christopher Noble, Massachusetts Institute of Technology
Elements for a Successful Startup

Michael D. O’Connor, Cruickshank Intellectual Property Attorneys
Software Patenting: Process and Strategy from the U.S. and International Perspectives

Sally O'Neil, Stanford University
Intellectual Property Terms in University-Industry Research Agreements and MTAs

Shinjiro Ono, Yuasa and Hara
Software Patenting: Process and Strategy from the U.S. and International Perspectives

Susan Patow, M.B.A., University of Minnesota
Successful Processes to Evaluate Inventions and Manage Stakeholder Expectations

Eric Payne, National Renewable Energy Laboratory
Top Ten License Negotiation Pitfalls and How to Avoid Them

Leigh A. Penfield, J.D., Johns Hopkins University
Ethics and Equitable Conduct: Procuring Enforceable Patents

Robert C. Penhallow, Bristol-Myers Squibb
Fostering Better Relations while Accelerating Transfer of Innovations to Big Pharma

Monique M. Perdok Shonka, Ph.D., J.D., Schwegman Lundberg & Woessner PA
Intellectual Property 101: Patents, Trademarks and Copyrights

Lili M. Portilla, M.P.A., National Institutes of Health
NIH Funding Essentials, Maintaining Inventions and Other Intellectual Property Issues

Lori Pressman, Harris & Harris Group, Inc.
New Strategies for Funding University Innovation
Understanding Incentives in the Diagnostic Marketplace
AUTM Debate Forum: Perspectives on Patenting Genomic Inventions

William F. Prout, Ph.D., Prout & Associates LLC
The Pros and Cons of a $1000 Provisional Patent Application

Ellen Purpus, Ph.D., Children's Hospital of Philadelphia
Royalty Monetization: Deal Structures and Outcomes

Charlie Raffin, Johnson & Johnson (Retired)
Understanding Incentives in the Diagnostic Marketplace

Christopher P. Rand, M.B.A., TriStar Technology Ventures
The Deal Points in a Preferred Stock Investment: Who Wants What and Why

Marina Ranga, Clayman Institute for Gender Research, Stanford University and Department of Technology and Society, Stony Brook University
Women in Technology Transfer: A Discussion on Rewriting the Rules

Robin L. Rasor, University of Michigan
AUTM Debate Forum: Role of Inventors in Negotiating License Transactions

Sidney P. Rattner, CPA, McGladrey & Pullen LLP
Strategies to Get Licensees to Pay

Brendan Rauw, Columbia University
Tuning-in to Your Expert Network

Fred H. Reinhart, M.B.A.,
Export Controls, MTAs and CDAs: What You Need to Know to Stay out of Trouble
One Patent Portfolio and Successive Licensees: A Tale of Two Technologies

Kristin Rencher, M.B.A., Oregon Health & Science University
Drafting the License Agreement: Let the Financial Terms Be Your Guide

George Renzoni, Christensen O'Connor Johnson Kindness PLLC
The Role of Non-Practicing Entities in Technology Commercialization

Rachel Repka, J.D., Sonnenschein Nath & Rosenthal LLP
Intellectual Property Enforcement Issues for Universities

Kathleen D. Rigaut, Ph.D., J.D., Dann Dorfman Herrell & Skillman
One Patent Portfolio and Successive Licensees: A Tale of Two Technologies
Global Patent Protection – Why You Need It and How to Get It

Mark L. Rohrbaugh, Ph.D., J.D., National Institutes of Health
Stem Cells: Presidents and Precidents

Michael F. Roizen, M.D., Cleveland Clinic Foundation Hospital
Physicians and Industry: Advancing Medicine Together

Matthew J. Rubin, Indiana University Research and Technology Corporation
Top Ten License Negotiation Pitfalls and How to Avoid Them

Helene Rutledge , GlaxoSmithKline
Sharing Data and Assets Across Industry and Academia to Drive the Science Base and Innovation

Frederique Sachwald, Ministre de l'Enseignement Suprieur et de la Recherche
Open Innovation and Public Research: Comparing American and European Practices

Scott Sanders , Cancer Prevention Research Institute of Texas
How to Get Angel Money

Arjun Sanga, J.D., The University of Texas System
Experiences with Collaborative Technology Transfer Programs

Manny W. Schecter, Esq., IBM Corp.
The Brave New World of Bilski

Billy Schulman, Stites & Harbison PLLC
Biotechnology and Life Sciences Patent Protection

Julie A. Scott, Polsinelli Shughart PC
Collaborative Agreements and Material Transfer Agreements in a Global Market

Susan Sedwick, Ph.D., The University of Texas at Austin
Export Controls, MTAs and CDAs: What You Need to Know to Stay out of Trouble

Sharon Semones, Eli Lilly & Co.
Academic-Industry Partnerships in Drug Discovery

Serge Shahinian, Ph.D., Goudreau Gage Dubuc
The Art of Protecting Life Science Inventions

Aurora L. Sharrard, Ph.D., Pittsburgh Green Building Alliance
It's Not Easy Being Green: The Challenges of Startups and Innovation in Cleantech

Todd T. Sherer, Ph.D., Emory University
Using In-reach As a Powerful Tool for Nurturing Relationships Inside Your University

Gina Shishima, Ph.D., J.D., Fulbright & Jaworski LLP
Ethics and Equitable Conduct: Procuring Enforceable Patents

D. Brian Shortell, Ph.D., J.D., Ballard Spahr Andrews & Ingersoll LLP
Intellectual Property Enforcement Issues for Universities

Andrew F. Sierakowski, University of Western Australia
Non-Revenue Benefits from Technology Transfer

Marc Singer, Osage University Partners
Launching Startups in a Down Market

Malcolm Skingle, Ph.D., GlaxoSmithKline
Fostering Better Relations while Accelerating Transfer of Innovations to Big Pharma
Sharing Data and Assets Across Industry and Academia to Drive the Science Base and Innovation

Vincent A. Smeraglia, University of Medicine and Dentistry of New Jersey
One Patent Portfolio and Successive Licensees: A Tale of Two Technologies

Gavin Smith, Lancaster University Business Enterprises, Ltd.
Non-Revenue Benefits from Technology Transfer

Tobin L. Smith, Association of American Universities
New Strategies for Funding University Innovation
Metrics and Public Policy

Jon Soderstorom, Ph.D., Yale University
Case Studies for Global Health: Building Relationships, Sharing Knowledge

Jon Soderstrom, Ph.D., Yale University
AUTM Debate Forum: Role of Inventors in Negotiating License Transactions
AUTM Debate Forum: Perspectives on Patenting Genomic Inventions

Rodney L. Sparks, Ph.D., J.D., University of Virginia Patent Foundation
The Pros and Cons of a $1000 Provisional Patent Application
Intellectual Property 101: Patents, Trademarks and Copyrights

Benjamin Spigel, University of Toronto
Technology Transfer Practitioners and Scholars: What Can We Learn from Each Other?

Tony Stanco, National Council of Entrepreneurial Tech Transfer
Creating and Funding Globally Competitive University Startups

Ashley J. Stevens, D. Phil. (Oxon), Boston University
Cash or Credit: Incorporating Students Into Daily Technology Licensing Office Operations

Ashley J. Stevens, D.Phil. (Oxon), Boston University
Creating and Funding Globally Competitive University Startups

Alexandra Stone, LBJ School of Public Affairs, The University of Texas at Austin
Technology Transfer Practitioners and Scholars: What Can We Learn from Each Other?

Gregory P. Sullivan, TreMonti Consulting LLC
Non-Traditional Departments As a Resource in Technology Transfer

John S. Swartley, Ph.D., M.B.A., University of Pennsylvania
Launching Startups in a Down Market

Kevin Sweeney, Polsinelli Shughart PC
Bankruptcy Issues in Licensing

Yetunde Taiwo, Eli Lilly & Co.
Academic-Industry Partnerships in Drug Discovery

C. Mark Tang, Ph.D. M.B.A. , World Technology Ventures LLC
Technology Licensing in China

Cengiz Tarhan, University College London
Non-Revenue Benefits from Technology Transfer

Robert H. Tieckelmann, SEMATECH, Inc.
Comparative Licensology: How License Terms Vary by Technology

Harl R. Tolbert, University of Rochester Medical Center
Academic-Industry Partnerships in Drug Discovery

Janna C. Tom, University of California
Access to Medicines: Fostering Partnerships, Overcoming Challenges

Simran Trana, Dow AgroSciences
Licensing Ag-Bio Technologies

Robert H. Underwood, McDermott, Will & Emery LLP
In re Bilski: Implications for Business Methods and Biotechnological Processes

Charles C. Valauskas, J.D., LL.M., Valauskas & Pine LLC
University – Industry Relations
Open Innovation: Where Has All My Intellectual Property Gone?
Software Patenting: Process and Strategy from the U.S. and International Perspectives

Ravi Venkataramani, Ph.D. , MedImmune, Inc.
Fostering Better Relations while Accelerating Transfer of Innovations to Big Pharma

Ann S. Viksnins, J.D., Viksnins Harris & Padys PLLP
How to Get Your Inventors Psyched, But Not Too Psyched!

Kathi Vosicky, KPMG
Strategies to Get Licensees to Pay

Stephen J. Weed, RatnerPrestia
You Can't Patent That! Can You?

Karen F. White, Purdue Research Foundation
The Pros and Cons of a $1000 Provisional Patent Application

Charles Williams, University of Oregon
Drafting the License Agreement: Let the Financial Terms Be Your Guide

Michael A. Williamson, Polsinelli Shughart PC
Bankruptcy Issues in Licensing

David Winwood, University of Alabama Birmingham
Startups: Learning from Real Life Experiences

Warren D. Woessner, Ph.D., J.D., Schwegman Lundberg Woessner & Kluth PA
You Can't Patent That! Can You?

Robert A. Wooldridge, M.B.A., Carnegie Mellon University
It's Not Easy Being Green: The Challenges of Startups and Innovation in Cleantech

Christopher F. Wright, J.D., McCausland Keen & Buckman
Launching Startups in a Down Market

Lili Wu, China Council for the Promotion of International Trade
Software Patenting: Process and Strategy from the U.S. and International Perspectives

Yingjie Wu, GlaxoSmithKline
Technology Licensing in China

Jessica Wyndham, American Association for the Advancement of Science and Human Rights
The Human Rights of Licensing

M. Guven Yalcintas, Ph.D., M.B.A., The Research Foundation of SUNY
Patent Reform Act: New Developments

Bin Yan, Ph.D., LL.B. , University of Miami W.H Coulter Center
Sharing Data and Assets Across Industry and Academia to Drive the Science Base and Innovation

Jordan E. Yarett, J.D., Paul Weiss Rifkind Wharton & Garrison LLP
Royalty Monetization: Deal Structures and Outcomes

Christopher Yochim, AstraZeneca
Fostering Better Relations while Accelerating Transfer of Innovations to Big Pharma

Aaron Young, Ph.D., Genzyme Corp.
Dealing with the Attack On The Patentability of Personalized Medicine and Diagnostic Patents

James R. Zanewicz, J.D., LL.M., University of Louisville
Don't Be Afraid: Media Training for the Technology Transfer Professional

Jay Z. Zhang, Myriad Genetics, Inc.
Dealing with the Attack On The Patentability of Personalized Medicine and Diagnostic Patents

Gordon Zong, Shanghai Institutes for Biological Sciences Chinese Academy of Sciences
Technology Licensing in China

John A. Zurawski, Pepper Hamilton LLP
Launching Startups in a Down Market